Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Oct 1, 2021
- Accession no.
- 0001447362-21-000231
- Filed
- Oct 1, 2021
- Trade date
- Sep 30, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions. Open-market sales total $823.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 | Common Stock | SSaleDisposed | −2,831 | $65.12F2 | −$184,354.72 | 293,187 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −5,469 | $66.13F3 | −$361,664.97 | 287,718 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −1,700 | $66.56F4 | −$113,152 | 286,018 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −266 | $65.09F6 | −$17,313.94 | 134,528 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −534 | $66.24F8 | −$35,372.16 | 133,994 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −33 | $66.64 | −$2,199.12 | 133,961 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −267 | $65.09F6 | −$17,379.03 | 157,367 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −533 | $66.24F8 | −$35,305.92 | 156,834 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −34 | $66.64 | −$2,265.76 | 156,800 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −267 | $65.09F6 | −$17,379.03 | 144,765 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −533 | $66.24F8 | −$35,305.92 | 144,232 | Indirect | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −33 | $66.64 | −$2,199.12 | 144,199 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $64.51 to $65.47, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $65.51 to $66.50, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $66.51 to $66.64, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $64.51 to $65.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $65.58 to $66.57, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.